---
$id: https://graph.org.ai/products/commodity/51111765
$type: Product
source: UNSPSC
code: "51111765"
title: "Trabectedin"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Trabectedin

**UNSPSC Code**: 51111765
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dna minor groove binding agent with the molecular formula C39H43N3O11S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ID0YZQ2TCP, chemically known as spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1(2h)-isoquinolin)-19-one, 5-(acetyloxy)-3,4,6,6a,7,13,14,16-octahydro-6,8,14-trihydroxy-7,9-dimethoxy-4,10,23-trimethyl-, (1r,6r,6ar,7r,13s,14s,16r)- but generally known as trabectedin, which bears US NIH Compound Identifier 108150. European Medicines Agency schedules Trabectedin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20756. The term TRABECTEDIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3, 2002, List 48). World Health Organization schedules trabectedin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule trabectedin under HS 29349990 and SITC 51579. As of Q4 2014, TRABECTEDIN remains the US FDA Preferred Term for this commodity. Trabectedin bears US NLM identifiers UMLS ID C1311070 and NCI Concept Code C1691. SMILES: S1C2C3N(C(O)C4N(C3C3C(C4)CC(C(OC)C3O)C)C)C(C3C2C(OC(=O)C)C(C2OCOC32)C)COC(=O)C2(NCCC3C2CC(OC)C(O)C3)C1.

